Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Accelerated Approval’s Double-Edged Sword Cuts Down Agenus’ Balstilimab BLA
Oct 23 2021
•
By
Bridget Silverman
US FDA's accelerated approval pathway offers unique benefits and vulnerabilities for sponsors. • Source: Alamy
More from Review Pathways
More from Pathways & Standards